NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
2.280
-0.110 (-4.60%)
At close: Jun 13, 2025, 4:00 PM
2.230
-0.050 (-2.19%)
After-hours: Jun 13, 2025, 7:55 PM EDT
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $7.20 million as of June 13, 2025. Its market cap has increased by 3.40% in one year.
Market Cap
7.20M
Enterprise Value
5.54M
1-Year Change
3.40%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $7.20M, a decrease of -64.19%. That is a compound annual growth rate of -20.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 7.20M | 110.45% |
| Dec 31, 2024 | 3.42M | -82.11% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.99B |
| Johnson & Johnson | 376.94B |
| Novo Nordisk | 353.21B |
| AbbVie | 339.89B |
| UnitedHealth Group | 288.92B |
| Abbott Laboratories | 237.40B |
| Novartis AG | 236.22B |
| AstraZeneca | 229.07B |